Beazimidazole compounds active as inhibitors of the cholesterol biosynthesis
US4940800A · kind A · utility
29Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1989 |
| Grant date | Jul 10, 1990 |
| Priority date | — |
| Expiry date | Jul 27, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds of formula ##STR1## wherein R, R.sub.1, R.sub.2, R.sub.3, and R.sub.4 have the meanings given in the specification, are described. The compounds of formula I are active as inhibitors of the enzyme HMG-CoA reductase and can be used in therapy as anti-hypercholesterolemics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.